Correlation Between Vicore Pharma and Immunovia Publ
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and Immunovia Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and Immunovia Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and Immunovia publ AB, you can compare the effects of market volatilities on Vicore Pharma and Immunovia Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of Immunovia Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and Immunovia Publ.
Diversification Opportunities for Vicore Pharma and Immunovia Publ
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vicore and Immunovia is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and Immunovia publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovia publ AB and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with Immunovia Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovia publ AB has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and Immunovia Publ go up and down completely randomly.
Pair Corralation between Vicore Pharma and Immunovia Publ
Assuming the 90 days trading horizon Vicore Pharma Holding is expected to under-perform the Immunovia Publ. But the stock apears to be less risky and, when comparing its historical volatility, Vicore Pharma Holding is 3.04 times less risky than Immunovia Publ. The stock trades about -0.13 of its potential returns per unit of risk. The Immunovia publ AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 148.00 in Immunovia publ AB on September 3, 2024 and sell it today you would lose (63.00) from holding Immunovia publ AB or give up 42.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vicore Pharma Holding vs. Immunovia publ AB
Performance |
| Timeline |
| Vicore Pharma Holding |
| Immunovia publ AB |
Vicore Pharma and Immunovia Publ Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vicore Pharma and Immunovia Publ
The main advantage of trading using opposite Vicore Pharma and Immunovia Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, Immunovia Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovia Publ will offset losses from the drop in Immunovia Publ's long position.| Vicore Pharma vs. Norion Bank | Vicore Pharma vs. Viaplay Group AB | Vicore Pharma vs. Nitro Games Oyj | Vicore Pharma vs. Media and Games |
| Immunovia Publ vs. Oncopeptides AB | Immunovia Publ vs. Hansa Biopharma AB | Immunovia Publ vs. Cantargia AB | Immunovia Publ vs. Camurus AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |